Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen L Reckamp
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
566 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Highlands Oncology Group - Fayetteville
Fayetteville, Arkansas, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- John L Mcclellan Memorial Veterans Hospital
Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Highlands Oncology Group - Rogers
Rogers, Arkansas, United States
- Highlands Oncology Group
Springdale, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Tower Cancer Research Foundation
Beverly Hills, California, United States
- Marshall Cancer Center
Cameron Park, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- City of Hope at Huntington Beach
Huntington Beach, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- City of Hope at Long Beach Elm
Long Beach, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente West Los Angeles
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Memorial Medical Center
Modesto, California, United States
- City of Hope Newport Beach
Newport Beach, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Kaiser Permanente-Ontario
Ontario, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Mar 2023
- Primary completion
- 26 Nov 2025
- Completion
- 15 Mar 2028
- Last update posted
- 17 Apr 2026
- Registered enrollment
- 838
- Registry id
- NCT05633602
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.